Offering HPV vaccine at age 9 linked to greater series completion.
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 47
- By:
- Publication type:
- Article
Works matching IS 1044307X AND DT 2023 AND VI 35 AND IP 10
Results: 10
1
2
Older women who get mammograms risk overdiagnosis.
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 46
- By:
- Publication type:
- Article
3
The safety of vaginal estrogen in breast cancer survivors.
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 46
- By:
- Publication type:
- Article
4
Can a novel, rapid-acting oral treatment effectively manage PPD?
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 43, doi. 10.12788/obgm.0310
- By:
- Publication type:
- Article
5
Contraception.
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 37, doi. 10.12788/obgm.0313
- By:
- Publication type:
- Article
6
Implementing shared decision making in labor and delivery: TeamBirth is a model for person-centered birthing care: The TeamBirth practice model infuses shared decision making into labor and delivery culture and workflow, vesting patients as partners in their care
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 32, doi. 10.12788/obgm.0311
- By:
- Publication type:
- Article
7
Have you asked your patients: What is your ideal outpatient gynecology experience? If not, consider using social media to ask. These researchers did, and they found that the perspectives expressed could help guide changes to improve patient satisfaction, well-being, and adherence to care
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 22, doi. 10.12788/obgm.0316
- By:
- Publication type:
- Article
8
The HPV vaccine: Time for ObGyn physicians to up our game: Although the HPV vaccine targets the strains responsible for about 90% of HPV-caused cancers, acceptance of the vaccine is disappointing. Now, we need to go the distance to increase HPV vaccination rates in our patients
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 16, doi. 10.12788/obgm.0312
- By:
- Publication type:
- Article
9
Do screening mammograms in women aged 70 and older improve stage at diagnosis or breast cancer-specific mortality?
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 12, doi. 10.12788/obgm.0314
- By:
- Publication type:
- Article
10
Nonhormonal medication treatment of VMS: For patients with bothersome vasomotor symptoms (VMS) who cannot or choose not to take estrogen, nonhormonal medication options include escitalopram, paroxetine, gabapentin, and fezolinetant.
- Published in:
- OBG Management, 2023, v. 35, n. 10, p. 5, doi. 10.12788/obgm.0315
- By:
- Publication type:
- Article